Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-25-331139
Filing Date
2025-12-23
Accepted
2025-12-23 17:15:04
Documents
4
Period of Report
2025-12-23

Document Format Files

Seq Description Document Type Size
1 PRE 14A itrm-20251223.htm PRE 14A 1660863
2 GRAPHIC img189820637_0.jpg GRAPHIC 3845
3 GRAPHIC img189820637_1.jpg GRAPHIC 622855
4 GRAPHIC img189820637_2.jpg GRAPHIC 225990
  Complete submission text file 0001193125-25-331139.txt   2836232
Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104
Business Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38503 | Film No.: 251601697
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)